ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000788.1|O-antigen_2 # 205 # 1200 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.422	BGC0000788.1|O-antigen_2 	205	1200	+	Loose	1190	29.6462	novA	32.76	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAACGATAACGTTTTGCTCATTGGTGCTTCCGGATTCGTAGGAACCCGACTCCTTGAAACGGCAGTGGATGATTTTAATATCAAGAACCTGGATAAACAGCAAAGCCATTTCTACCCAGAGATTACACACATTGGCGATGTTCGTGACCAACAAATCCTTGACCAGACGTTGGTGGGTTTTGACACCGTAGTACTATTGGCTGCGGAGCATCGTGATGATGTTAGTCCTACCTCGCTTTATTATGATGTCAACGTCCAGGGAACGCGTAATGTACTGGCGGCGATGGAAAAAAATGGTGTAAAAAATATCATTTTTACCAGTTCCGTTGCAGTTTATGGACTCAACAAGAAAAATCCTGACGAAACGCACCCTCACGATCCCTTTAATCATTACGGAAAAAGTAAATGGCAAGCAGAAGAAGTTCTGCGTGAGTGGCATGCTAAAGCGCCGAATGAGCGTTCTTTGACCATAATTCGTCCTACCGTTATTTTCGGGGAGCGTAACCGCGGTAATGTATACAATCTCTTGAAACAGATCGCTGGTGGTAAATTTGCGATGGTTGGTCCGGGAACTAACTATAAATCAATGGCTTATGTTGGTAATATCGTTGAGTTTATCAAATTCAAACTCAAGAATGTTACGGCGGGCTATGAAGTTTATAATTATGTTGATAAACCTGATCTGAATATGAATCAATTGGTTGCTGAAGTAGAGCAGAGCCTGGGCAAAAAAATACCATCGATGCACCTTCCATATCCATTAGGTATGCTGGGGGGTTACTGTTTCGATATCCTGAGCAAAGTAACGGGCAAGAAGTACGCTGTAAGTTCGGTTCGTGTTAAAAAATTCTGTGCGACAACGCAGTTTGATGCAACAAAAGTGCATTCTTCTGGTTTTGTTGCGCCATACACCTTATCTCAGGGGTTGGATCGTACACTGCAATATGAATTTGTTCATGCAAAGAAAGATGACATTACATTCGTTTCAGAGTAA	MNDNVLLIGASGFVGTRLLETAVDDFNIKNLDKQQSHFYPEITHIGDVRDQQILDQTLVGFDTVVLLAAEHRDDVSPTSLYYDVNVQGTRNVLAAMEKNGVKNIIFTSSVAVYGLNKKNPDETHPHDPFNHYGKSKWQAEEVLREWHAKAPNERSLTIIRPTVIFGERNRGNVYNLLKQIAGGKFAMVGPGTNYKSMAYVGNIVEFIKFKLKNVTAGYEVYNYVDKPDLNMNQLVAEVEQSLGKKIPSMHLPYPLGMLGGYCFDILSKVTGKKYAVSSVRVKKFCATTQFDATKVHSSGFVAPYTLSQGLDRTLQYEFVHAKKDDITFVSE	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	53.82	gnl|BL_ORD_ID|1112|hsp_num:0	1210			1158	1314	novobiocin
BGC0000788.1|O-antigen_3 # 1200 # 1316 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.453	BGC0000788.1|O-antigen_3 	1200	1316	+	Loose	475	23.0978	AAC(6')-Ib7	38.71	3002578	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCCCTGGCGTTGTAATGATGCTCTATTTGCCGATGAAGTATCGGGTGCCATGCTGGGTATATCAATGTACTCAATTCCGAGTAATCTGAATACCCACAGTGCTGATGAAGTGTAG	MPWRCNDALFADEVSGAMLGISMYSIPSNLNTHSADEV	MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	14.56	gnl|BL_ORD_ID|1914|hsp_num:0	2117			153	246	amikacin; kanamycin A; tobramycin
BGC0000788.1|O-antigen_4 # 1443 # 2336 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.507	BGC0000788.1|O-antigen_4 	1443	2336	+	Loose	500	25.7942	amrA	48.39	3002982	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTAATTTGAAAGCAGTTATACCGGTAGCGGGTTTGGGTATGCACATGTTGCCTGCCACCAAGGCAATCCCAAAAGAGATGCTACCGATCGTCGACAAACCAATGATTCAGTATATTGTCGATGAGATTGTGGCTGCAGGGATCAAAGAAATCGTGCTGGTGACTCACGCGTCTAAAAATGCCGTTGAGAACCACTTCGACACCTCTTATGAACTTGAATCACTTCTTGAGCAGCGCGTTAAGCGCCAGCTTCTGGCGGAAGTACAATCTATCTGTCCTCCGGGCGTGACAATTATGAACGTTCGTCAGGCGCAGCCATTAGGACTGGGGCACTCTATTCTGTGCGCGCGTCCGGTGGTGGGTGATAACCCTTTCATCGTAGTACTTCCGGATATTATTATTGATGATGCTACCGCCGATCCGCTGCGCTATAACCTTGCGGCGATGGTGGCGCGCTTCAATGAAACGGGTCGCAGCCAGGTACTGGCGAAGCGCATGAAAGGCGATTTATCGGAGTATTCTGTTATTCAGACGAAAGAACCTCTGGATAATGAAGGCAAAGTCAGCCGGATTGTGGAATTTATCGAAAAACCGGACCAGCCGCAGACGCTGGACTCCGATTTGATGGCAGTAGGCCGTTATGTGCTTTCAGCCGACATCTGGGCGGAATTGGAAAGAACCGAACCGGGCGCCTGGGGCCGCATCCAGCTCACGGATGCCATTGCTGAGCTGGCGAAAAAACAGTCGGTTGACGCAATGCTGATGACGGGCGACAGCTATGACTGCGGTAAAAAAATGGGCTACATGCAGGCATTTGTGAAATACGGGCTGCGTAACCTGAAAGAAGGGGTGAAGTTCCGTAAGAGCATAGAGCAGCTATTGCATGAATAA	MTNLKAVIPVAGLGMHMLPATKAIPKEMLPIVDKPMIQYIVDEIVAAGIKEIVLVTHASKNAVENHFDTSYELESLLEQRVKRQLLAEVQSICPPGVTIMNVRQAQPLGLGHSILCARPVVGDNPFIVVLPDIIIDDATADPLRYNLAAMVARFNETGRSQVLAKRMKGDLSEYSVIQTKEPLDNEGKVSRIVEFIEKPDQPQTLDSDLMAVGRYVLSADIWAELERTEPGAWGRIQLTDAIAELAKKQSVDAMLMTGDSYDCGKKMGYMQAFVKYGLRNLKEGVKFRKSIEQLLHE	MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRLDAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHLAALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASARAELARAQLQLDYATVTAPIDGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQQDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDRAVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVVVVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST	74.44	gnl|BL_ORD_ID|1419|hsp_num:0	1542			867	960	
BGC0000788.1|O-antigen_5 # 2543 # 2755 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=13bp;gc_cont=0.333	BGC0000788.1|O-antigen_5 	2543	2755	-	Loose	550	25.409	LRA-8	23.81	3002487	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGTATGTGCAAAATTTTAATCATATATTACAACATCCTGAAAAATATAAATTCGACATAATATCAACGCATAAAAATTTATTAAAAGAAATACAAATTAATTTTTCTATAATTAGTACGCTACCGCCCCTGGCTCATCAGCTACCAGTGCACTGCGTACATATCGATTTGTCACAACCCTCGCCACTCCAGGCAAAGCTCACTAAAACTTAA	MYVQNFNHILQHPEKYKFDIISTHKNLLKEIQINFSIISTLPPLAHQLPVHCVHIDLSQPSPLQAKLTKT	MSKSSLKGLVLLALVAAIAAPSWAARKEKPAAKAPPCEQCAVWNADQEPFKIWGNTYYVGVKGLSSVLVTSDWGHVLLDGGLPESAPKIAANIEKLGFKVTDVKAILSSHVHADHAGGIAELQRRSGAKVYQRRPSDQVLRTGKPDPGDPQLARAGPIPPVENVWVVHDEELLGLGPTRFTVVATPGHTPGGTSWAWESCEGAQCLKIVYADSLNAVSAEGFRFTASTTYPNVLQDLEQSFKRVESLPCDVIVSVHPEQSDFFPRMAKRVDGKPESIKDPEGCKRYVAGARERLALRVASEKQGS	22.95	gnl|BL_ORD_ID|663|hsp_num:0	718			624	744	
BGC0000788.1|O-antigen_6 # 2834 # 3847 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=15bp;gc_cont=0.292	BGC0000788.1|O-antigen_6 	2834	3847	+	Loose	700	47.7506	LpsB	22.03	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGGTTTGTTCTAAGGCTGGAAATTTTACAGCTCAGGCTAATGAAGTGGGTGTACAAACTTTTGTTATAAGAACTCTAGTACGGAAAATTTCTTTTTATAAAGATCTTAAATCCTTTATTGAATTATATAGACTAATTAAAAAGGAAAAATATGATATTATCCATACCCACTCATCGAAAACTGGTTTTTTAGGACGACTTGCAGCAAAACTAGCCGGAACAAAAAAAATAGTTCACACGGTTCATGGTTTCGCTTTCCCATCTACAAAAAATAAAATTTTTAAAGCTATATATTTTCTTATGGAATATATAGCTTCGCTATGCACATCTGTTATCATTGTTATGAATAAAAATGATGAAATAATTGCAAGAAAATATTTTTGTGCAAATGCAAAAACGAAATTAATATTATTGAATAATGCTATAGATATTAGTAGGTTTGATAAGTTGGTTACAAATGGTTCATCAATGAATAGTAAAAAAAGAACTAAAAATAAATTTAAGCTTGTTATGGTTGGAAGGTTATGTGAACAAAAAAACCCATTATTGGTTCTCGAGGCAATAAAGAAACTTAATAATGATTTTTCCATAGATTTTATAGGCGATGGGCCTTTAAAAGAAGAAGTACAAAATAAAATAATAGAATATGGTATAGCTGAAAGAGTTAAATTATTAGGGTGGTGTGTTTCGGTAGAGGATATTTTATATAAATATGATCTTTTTGTTTTGCCATCAAAATGGGAAGGAATGCCTTTGGCTATTTTAGAAGCAATGGCAGCAAAGATCCCTGTTTTATGTTCTGATATCGACGCCAATCGCTATCTCTTAGGTAAGACATCTGGTTTTTTATTTAAAAGCGAAGATAGTGACGATTTTGCTAATAAAATTAAATTTCTTTATGAAAATGATGAAATTCGTCAGACTGCTGTTCAAGAAGCATATTCTTTAGTAGTCAATGATTTTGATTTATGTAAACGAACTAAGATCTTGGAATCAATATATACACATAATTAA	MVCSKAGNFTAQANEVGVQTFVIRTLVRKISFYKDLKSFIELYRLIKKEKYDIIHTHSSKTGFLGRLAAKLAGTKKIVHTVHGFAFPSTKNKIFKAIYFLMEYIASLCTSVIIVMNKNDEIIARKYFCANAKTKLILLNNAIDISRFDKLVTNGSSMNSKKRTKNKFKLVMVGRLCEQKNPLLVLEAIKKLNNDFSIDFIGDGPLKEEVQNKIIEYGIAERVKLLGWCVSVEDILYKYDLFVLPSKWEGMPLAILEAMAAKIPVLCSDIDANRYLLGKTSGFLFKSEDSDDFANKIKFLYENDEIRQTAVQEAYSLVVNDFDLCKRTKILESIYTHN	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	92.08	gnl|BL_ORD_ID|2781|hsp_num:0	3793			99	900	colistin A; colistin B; defensin
BGC0000788.1|O-antigen_7 # 4091 # 4555 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.581	BGC0000788.1|O-antigen_7 	4091	4555	-	Loose	700	24.2534	tet(41)	40.62	3000569	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCCCCAGTCGCGCAGCGAGTCCATGTTGCCGAGATACAGACAGGACTCCAGTCCCTGGGCGATATTGGCGATGGCGCGGGTGATCTTACGGGTGACGAAGGTTTCGCCGCGACGCGGAGATTCGTGGTTAAACAGAATGCCGTTACAGGCGTAAATACCGTAGGATTCACGGTAGTTGACGGTGATCCAGTAGGCGTACAGTTTCGCCACCGCATAGGGGGAACGCGGGTAGAACGGCGTGGTCTCTTTCTGCGGGATCTCCTGCACCAGACCGTACAGTTCAGAGGTGGAAGCCTGGTAGAAACGCGTTTTCTTTTCAAGACCGAGGAAGCGGATTGCCTCCAGCAGGCGCAGCGTGCCCATCGCATCCACATCGGCGGTATATTCCGGCGACTCAAACGACACCGCCACGTGGCTCATCGCGCCCAGGTTGTAGACCTCATCCGGCTGTACTTCCTGTAA	MAPVAQRVHVAEIQTGLQSLGDIGDGAGDLTGDEGFAATRRFVVKQNAVTGVNTVGFTVVDGDPVGVQFRHRIGGTRVERRGLFLRDLLHQTVQFRGGSLVETRFLFKTEEADCLQQAQRAHRIHIGGIFRRLKRHRHVAHRAQVVDLIRLYFL	MKKPMLVILLTVLLDAVGIGLIMPILPALLRSLGGLDAGSVHYGALLAAYALMQFLFSPILGALSDRFGRRPVLLISLAGAAADYLLMAFAPTLAWLYLGRLLAGITGANMAVATAYVTDITPVGQRARRFGLVGAVFGVGFIVGPLLGGSLGEWHLHAPFLAAAMMNALNLVMAFFLLPESRKSRPRAAEKIRLNPFSSLRRLHGKPGLLPLAGIYLVMALVSQAPATLWILYGQDRFGWSMMVAGLSLAGYGACHALSQAFAIGPLVARLGERKALLIGLAADAVGLALLSVATRGWAPFALLPFFAAGGMALPALQALMAHKVDDDHQGELQGTLASMGSLIGVAGPLVATALYAATRDVWPGLVWALAAALYLVVPPLLARSRARDAAP	39.19	gnl|BL_ORD_ID|1486|hsp_num:0	1584			987	1083	tetracycline
BGC0000788.1|O-antigen_8 # 4586 # 4987 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.550	BGC0000788.1|O-antigen_8 	4586	4987	+	Loose	730	28.8758	ceoA	44.12	3003009	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTACAGCAGGAGCAGCCGGAAGATTTCGTGATTGCCACCGGCGTGCAGTATTCCGTACGCCAGTTTGTGGAGCTGGCGGCGGCGCAACTGGGGATAAAACTGCGCTTTGAAGGCGAAGGCATTGATGAGAAAGGGATCGTGGTATCCGTGACCGGACACGATGCGCCGGGTGTGAAACCGGGCGATGTGATTGTGGCCGTTGATCCGCGCTATTTCCGTCCGGCGGAAGTGGAAACCCTGCTGGGCGACCCGTCCAAAGCGCATGAGAAACTGGGCTGGAAACCGGAAATCACCCTGTCGGAGATGGTCTCCGAGATGGTGGCGAACGATCTGGAGGCCGCGAAAAAACACTCACTGCTGAAATCTCATGGATTCGATGTAAATTTATCTTTGGAATAA	MLQQEQPEDFVIATGVQYSVRQFVELAAAQLGIKLRFEGEGIDEKGIVVSVTGHDAPGVKPGDVIVAVDPRYFRPAEVETLLGDPSKAHEKLGWKPEITLSEMVSEMVANDLEAAKKHSLLKSHGFDVNLSLE	MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVSANAPEKAAAPLPEVDVATVVPQTVTDWQSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLAAAQARNGYAQTDWQRAQRLIGDNAIAKRDYDEKQNAAREAKREPEGRRSRAGNGAHQSRLYAHHRAGVGPRVARGNHARQRRVGRRVGRAADDAGIGVADLRVVRRRRADLPAIHQRRAQRPQGAGRARPRERNRLLAQRRDRFGRQPARHVVRHDPRARPLRQRGRHPGPGPLRTREGGRQRAARGAARRRRGDQHRPGQEVRVRRRPAGPRVVSRSAARDAARQPARDRERAVGRRPRGRERHAARASGRAGEAAHGPDDGRRCAVRAVASTAKPAAPAKADS	32.84	gnl|BL_ORD_ID|1576|hsp_num:0	1719			240	339	
BGC0000788.1|O-antigen_10 # 5469 # 5663 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.641	BGC0000788.1|O-antigen_10 	5469	5663	-	Loose	1900	22.7126	MexW	47.83	3003031	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCGACAGCATCGGGTCGGTGTTCTCCTGCCACACTTCGCGCGCCAGCTCCATCACGTGAATGCTGGCCGCCGCCATATCATCAACGTGCAGAAATTCGCGCATCGGCGTTCCGCTGCCCCACACCACCACTTCCGGCGCGTGGCTCTGCACGGCCTCATGAAAGCGGCGCAGCAGCGCCGGGATCACGTGTGA	MRQHRVGVLLPHFARQLHHVNAGRRHIINVQKFAHRRSAAPHHHFRRVALHGLMKAAQQRRDHV	MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH	6.29	gnl|BL_ORD_ID|2018|hsp_num:0	2208			2742	2811	erythromycin; acriflavine; tetracycline; chloramphenicol
BGC0000788.1|O-antigen_11 # 5682 # 5903 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=TAA;rbs_spacer=13bp;gc_cont=0.604	BGC0000788.1|O-antigen_11 	5682	5903	+	Loose	750	22.7126	MexE	60.0	3000803	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGACTGCACTATCCGCGAGCTGGCGCAGACCATCGCGAAGGTGGTGGGTTACAAAGGCCGGGTGGTGTTCGACGCCGCGAAGCCGGACGGCACGCCGCGTAAATTACTCGACGTCACGCGCCTGCACCAGCTTGGCTGGTATCACGAAATTTCACTGGAGGCAGGGCTTGCCGGTATTTACCAGTGGTTCCTTGATAATCAGCAGCGGTTCCGGGGGTGA	MDCTIRELAQTIAKVVGYKGRVVFDAAKPDGTPRKLLDVTRLHQLGWYHEISLEAGLAGIYQWFLDNQQRFRG	MEQSSHFSWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLEAPESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQARSVNEAQRGERLRASNAISAELADARTTAAQEAKAAVAATQAQLDAARLNLSFTRITAPIDGRVSRAEVTAGNLVNSGETLLTTLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESPVYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTYAATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGLQRVRPGMQVDPQKVEMASADTLATLARLRQSVGDSEPPKVAASKDNATRNEPRG	17.63	gnl|BL_ORD_ID|1038|hsp_num:0	1067			813	858	ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
BGC0000788.1|O-antigen_12 # 5906 # 6406 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.557	BGC0000788.1|O-antigen_12 	5906	6406	+	Loose	770	27.7202	tet(V)	48.0	3000181	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTTTTACGCAAGGAAGATTTCGCCGCTGTGGTGCGTACCACGCCCCTTATTGCCCTCGATTTCATCGTGGAAAACGACCAGGGGGAAATCCTGCTGGGCCAGCGTCTCAACCGTCCGGCGCAGGGCTACTGGTTTGTGCCGGGGGGGCGGGTGTGCAAAGACGAAACGCTGGAGGCTGCCTTCGAACGCCTGACGCAGGCGGAACTGGGCGTGCGTCTGCCGCTGGCGGCAGGGACGTTTTATGGCGTGTGGCAACACTTCTATGACGACAACTTTTCCGGAGAGGATTTTTCAACTCACTACATCGTGCTCGGCTTTCGTCTGCGCATGGCGGAGAGCGATTTACACCTGCCTGACGACCAGCATGGCGGTTACCGCTGGCTGACGCCGGAACAGCTTCTGGCAGGCGACAATGTTCATGATAACAGTCGGGCTTATTTTCAAAAAGCACCCTATTCTGTCATTGGTTTAGACAAAAAGGACGTCAAGTATGTCTGA	MFLRKEDFAAVVRTTPLIALDFIVENDQGEILLGQRLNRPAQGYWFVPGGRVCKDETLEAAFERLTQAELGVRLPLAAGTFYGVWQHFYDDNFSGEDFSTHYIVLGFRLRMAESDLHLPDDQHGGYRWLTPEQLLAGDNVHDNSRAYFQKAPYSVIGLDKKDVKYV	MRSPRPVAGWRVLAPFRIREYRLLIAAVTLSIFAEGMWSVVMALQVIAIDNDPASLSLVATCLGVGLVAFVLVGGITADRINQRTIIIAVEVVNFVTVAVISALALLGVLKIWHMAVAAGILGIAAAFFFPAYSAILPRILPPEQLLAANGVEGVVRPVFQRSVGPAVAGMVIGATMPSIGAVVVAVLFALGLALLVATRPPAQPASEHHERPHVLRDLREGFAFVLKTPWLLWTVLFASMFVLVVLGPIEVLLPFIAQDRFADGARAYGFILAFFGIGSAMGALTVSSRRMPRRYLTTMMLMWGLGSIPLVIVGYTSSFPLMAAATFVIGVTDGAGMVIWGTLLQRRVPTEMLGRVSSLDFFVSLAFMPLSFAIVGPLSKVVSMEVIFATAGLVPVAIAAVAFTAARMHRDEVANPLL	39.62	gnl|BL_ORD_ID|1041|hsp_num:0	1006			414	489	tetracycline
BGC0000788.1|O-antigen_13 # 6399 # 7847 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=13bp;gc_cont=0.393	BGC0000788.1|O-antigen_13 	6399	7847	+	Loose	800	26.5646	cprS	23.88	3005064	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	pmr phosphoethanolamine transferase	ATGTCTGATGTGCCCTTAATTGCTGTAGTAATGGCTGGTGGTACGGGGAGCCGTCTTTGGCCTCTATCTCGGGAACTCTACCCAAAACAATTTTTACAGTTTTCTGGAGAGAATTCCTTATTACAGACAACCCTGCTTCGGCTGTCGGCACTTGCCTGTAAAGATCCATTAGTCATAACAAACGAGCAGCACCGTTTTATTGTTGCGGAACAGTTACGGCAAATAGATCAACTTCACGATAACATTATTCTTGAGCCGTGTGGGAGAAATACGGCTCCAGCGATTGCGCTTGCTGCATTTTCGGCGCTTAAACGTAATGAGCAGGAGGATCCTTTACTTTTGGTTCTTGCAGCTGATCATGTTATCGCTAAAGAAAATGTTTTTTGCAACGCTATTAAGAAAGCAGTGCCAATTGCCGAAAATGGTAATATTGTTACATTTGGTATCATACCTGAGTATGCAGAAACTGGTTATGGTTATATAGAGCGTGGTGCACTGTTCTCGGTAAACGGAAATTCAACTGAAACAAGTTTTTATCATGTGAGAAATTTTGTTGAAAAGCCGGATCGATTGACAGCAGAAAAATATATCTCTACAGGGAACTATTTCTGGAATAGTGGCATGTTTATGTTTAAGGCCAGTGTTTATCTGAATGAGTTAAAAAAATTTAGACCGGATATTTATAGTGTTTGTGAACAGGTGGTTTCTGCCTCATATCGTGATCTTGATTTTATTCGTATTCCTGAAGCTTTGTTTAAAGATTGTCCTGCAGAATCTATTGATTTTGCTGTTATGGAAAAAACGGAACATTGCATTCTTTGTCCAATTGATATCGGTTGGAGTGATGTTGGTTCCTGGCAGTCTCTGTGGGATATCAGCGAAAAAACCGATGAGGGAGATGTTTGTAAAGGTGATATCCTGACATATAACACTAAAAATAATTATATATACTCAGAGTCAGCATTGGTTGCTGCTGTAGGTGTTGAGGATATTGTTATTGTACAAACAAAAGATGCCATACTGGTTTCTAAAAAATCTGACGTGCAGGATGTAAAAAAAATCGTTGAAATGCTAAAGGCGCGAGATCGTACAGAATATATTTCTCATCATGAGGTTTTTCGCCCCTGGGGTAAATTTGACTCAATAGATCAGGGCGAGCGATATAAGGTCAAGAAGATTATCGTAAAACCTGGAGAAGGGCTTTCTTTACGTATGCATCATCATCGTTCAGAACACTGGATTGTACTTTCTGGTACAGCTAAAGTTACCCTGGATGATAAAACGATGCTAATTACCGCAAATGAATCGATTTATATCCCACTGGGTGCAACTTACAGTCTGGAGAATCCAGGAGTTATTCCTCTTAATCTCATCGAAGTTAGTTCAGGCGATTATTTGGGAGAAGATGATATCGTTCGGCAGAAAGAACGTTACAGAAAAGATAATTAA	MSDVPLIAVVMAGGTGSRLWPLSRELYPKQFLQFSGENSLLQTTLLRLSALACKDPLVITNEQHRFIVAEQLRQIDQLHDNIILEPCGRNTAPAIALAAFSALKRNEQEDPLLLVLAADHVIAKENVFCNAIKKAVPIAENGNIVTFGIIPEYAETGYGYIERGALFSVNGNSTETSFYHVRNFVEKPDRLTAEKYISTGNYFWNSGMFMFKASVYLNELKKFRPDIYSVCEQVVSASYRDLDFIRIPEALFKDCPAESIDFAVMEKTEHCILCPIDIGWSDVGSWQSLWDISEKTDEGDVCKGDILTYNTKNNYIYSESALVAAVGVEDIVIVQTKDAILVSKKSDVQDVKKIVEMLKARDRTEYISHHEVFRPWGKFDSIDQGERYKVKKIIVKPGEGLSLRMHHHRSEHWIVLSGTAKVTLDDKTMLITANESIYIPLGATYSLENPGVIPLNLIEVSSGDYLGEDDIVRQKERYRKDN	MKRGLSLIPIVGGGVTLILAGVLLVYTRMLGDYGETGALYLLSMMMEEEGLYFAQRYQEDPATPAPDSYYFKGSVGTAGLPPKLREMLDTPPYKSIGAMQLLGNWDDDDEEEDDDAPSDDAYVVVRQPLADGKTLYLYDNDAAGSIDTPLSDAIIDARVRQTWIVTLSVTLPSLAAVGLLVWFIVAPLRKLTRWSMTLDDLAPDSQRPRFNYRELNVLADTLWNSVTRIKDFSQREERFLRYASHELRTPLAVIGMNLELLDQPGRAPSPHALQRIRRSALGMQQMTETLLWLSRESGELRDDGHIEVGRLLEELLEEQQALSQRRGLTFHLDVEPHSLPQTRARIIIGNLLRNALQYSDEGVVEIVVRDRSLLISNPIGAAQGTEESMAFGYGLGLDLVQRLCQKSGWRLHYSSDEQRFRCELLFPATPD	111.83	gnl|BL_ORD_ID|2789|hsp_num:0	3804			21	222	polymyxin B; colistin A; colistin B
BGC0000788.1|O-antigen_14 # 8034 # 8684 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=TAA;rbs_spacer=13bp;gc_cont=0.616	BGC0000788.1|O-antigen_14 	8034	8684	-	Loose	1900	25.409	mexN	29.55	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTTTTTCCAGAAACGCTTCCGCCAGCAGGCCGACGATGTAGTACCCCTCGATAAACTGCCCTTTTTCATCAAACAGGAAGCAGCGGTCGAAGTCGCCGTCAAAGGCGATGCCCATGTCCGCCCCGTGTTCAATAACGGCGTTCCGGGTGTCGTCGCGACACTCCGGCAGCAACGGGTTGGGAATGCCGTTCGGGAAGGTGCCGTCCGGGGTGTTGTGGATTTTGATGAACTCCACCGGCGCGCCCAGCGCCTTCAGGCGCGCTTCGATGGCGTCGATGACCGGCCCCGCCGCGCCGTTGCCGGAATTCACCACCAGCTTCAGCGGGGTGAGATTTTTAACACTGATGTAGCTGAGCAGGTGGTCGATGTAGGCGTCACGCAGGGTGATTTGTCTGTAGCTGCCGCGCGCGGCGTCGTTCACCGGCGGGAAGTCGTTGGCCTCCGCCAGGCGCTGAACGTCGCGCAGACCGGTGTCGCCGCTTATCGGGCGGGCGCCCTCTCGCACCAGCTTCATGCCGTTGTAATCCATCGGGTTATGGCTGGCGGTCACTTCAATACCGCCGTCCACGCCGAGGTGGAAGGTGGCGAAGTAAATCTCTTCAGTGCCGGACATACCGATATCCAGCACGTCGACGCCTGCATCCTGTAG	MFFQKRFRQQADDVVPLDKLPFFIKQEAAVEVAVKGDAHVRPVFNNGVPGVVATLRQQRVGNAVREGAVRGVVDFDELHRRAQRLQARFDGVDDRPRRAVAGIHHQLQRGEIFNTDVAEQVVDVGVTQGDLSVAAARGVVHRREVVGLRQALNVAQTGVAAYRAGALSHQLHAVVIHRVMAGGHFNTAVHAEVEGGEVNLFSAGHTDIQHVDACIL	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	20.85	gnl|BL_ORD_ID|2021|hsp_num:0	2217			768	1011	chloramphenicol; thiamphenicol
BGC0000788.1|O-antigen_15 # 8769 # 9170 # -1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.637	BGC0000788.1|O-antigen_15 	8769	9170	-	Loose	500	23.483	CTX-M-81	24.18	3001942	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	TTGTTTACCTTTAGACTCCACATTCAGGCGCACCACCGGTTCGGTGTTCGACGAACGCAGGTTGAAGCGCCAGTCGGCGAACGACATGCTGATGCCGTCCGTGCGGTCCACCGCCAGCGCCTCGCCGGCAAAATGCCGCTCCACCCGGGCAATCGCCGCCGCCGGCTCCGCCAGCCTGCTGTTGATTTCCCCGCTCGCCGGGTACGCCGCCATCCGGTCGCGGACCAGTTCACCCAGCGACTGCCCCTTCAGGCACACCAGCTCCGCCACCAGCAGCCACGGGATCATCCCGCTGTCGCAGTAAGCAAAATCGCGGAAATAGTGATGCGCGCTCATCTCGCCGCCATACACCGCATCCTCAAGACGCATCCGCTCCTTGATAAAGGCGTGCCCGGTTTTTGA	MFTFRLHIQAHHRFGVRRTQVEAPVGERHADAVRAVHRQRLAGKMPLHPGNRRRRLRQPAVDFPARRVRRHPVADQFTQRLPLQAHQLRHQQPRDHPAVAVSKIAEIVMRAHLAAIHRILKTHPLLDKGVPGF	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLEQSETQKQLLNQPVEIQPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDHTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL	45.70	gnl|BL_ORD_ID|658|hsp_num:0	713			264	534	
BGC0000788.1|O-antigen_16 # 9230 # 10096 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=14bp;gc_cont=0.328	BGC0000788.1|O-antigen_16 	9230	10096	+	Loose	500	24.6386	OXA-63	40.74	3001764	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAAATAGTTGTGATAAGGTTGACTGGAGGGTTAGGCAATCAACTTTTCCAATACGCTATGGGTTATGCTGAAGCAAAAGAGCAAAATTGTCAGCTGAAAATAGATCTGCGTGGCTATAAAAAATATCACTTACATGGTGGCTATCGTTTAAATAATTTAAAAATTAAACCTGCAATGCTTACAAAAAGAGAGATGTTATATTTTCCGAATATACTAGTTCGCGCTATAAATAGATATCCTAGATTATCTTTATATCTAAAGAGGTTTGAGTCAGAATATTTTTCAGTGAAAAATAAAGAACATAGTAAGTCAATCGAATTTATTGGCTTTTGGCAAAATGAACAATATTTTAAAAGATATAAAAATGAGTTGCGTAAAATATTTACTCCTGTGAATATAAGTTCAGATGTTTTGAAACTTAAAGAAAGAATACAAGGACAAAATTCTATTGCTCTCCATATTAGGCGAGGCGATTATATATCTAATCATGAGGCAATGAATACTCATGGGGTTTGCTCCTTGAATTATTATATTTCCAGTGTGTCTTATGTTAAGGGAATGGTTGCTAACATTTCTTTTTTTGTATTCAGTGACGATATACAATGGTGCAAGGAAAATGCAAGAGAAATATTTAATAGTGATGATGAAGTCAACTATGTTGAAGGCAATAGTCAGGAGGTAGATATGTGGCTAATGTCAGCAGCGAAGCACCATATCATAGCAAATAGCTCTTTTAGTTGGTGGGGAGCATGGCTTGCTAGGGATGCAAATAATATGACAATTGCACCAATTCCATGGTTTGATAAAAAAGAACTTTCAGGATTTGATCCGTGTCCAGAAAGTTGGATAAGAATTAAAAAATAA	MKIVVIRLTGGLGNQLFQYAMGYAEAKEQNCQLKIDLRGYKKYHLHGGYRLNNLKIKPAMLTKREMLYFPNILVRAINRYPRLSLYLKRFESEYFSVKNKEHSKSIEFIGFWQNEQYFKRYKNELRKIFTPVNISSDVLKLKERIQGQNSIALHIRRGDYISNHEAMNTHGVCSLNYYISSVSYVKGMVANISFFVFSDDIQWCKENAREIFNSDDEVNYVEGNSQEVDMWLMSAAKHHIIANSSFSWWGAWLARDANNMTIAPIPWFDKKELSGFDPCPESWIRIKK	MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKERAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKLMAKSFLESWAKDSNLRYAIKNSQVPAYKELARRIGIKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQNELQYPIEIQKAISDITITRANLHITLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK	107.46	gnl|BL_ORD_ID|718|hsp_num:0	782			594	675	cloxacillin; oxacillin; cefalotin
BGC0000788.1|O-antigen_17 # 10108 # 11085 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=TAAAAA;rbs_spacer=15bp;gc_cont=0.266	BGC0000788.1|O-antigen_17 	10108	11085	+	Loose	600	25.0238	clbB	34.88	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGTTCAAAAAGAAAAGTATATTTGTTTTTTTAGGGCTTCTTAGCTCTATACTTCTTGCGTTACCTTTAGCTATGCAAGGCGGTTTTGATGATTCCTTAGTTTACTATTCACAAGCTGATTATATATGGAGTTACGGTTTATATGATGGACTAAGAGCTATTTATATCCAAACAAATAAATTTGAGCCCGCTATGGGGCTACTATTTTTTATAGAAGGGTTTATTGTTACCGAAAAATTCTATTTTTTATTACTTAATTTAACACTAGTGAATTTTATTACAGTTTTGATATATATAAAAATTAATGAACAATCAAATACAAGTATAAGTTTTATATATGCAATACTATTGCTCTCTACATATTATATTTTTTCTAATAATATTTACGTGTGGAGGACTATCATTTCTTTATACTTTTTTATTTTGTTTGTTTTTTCTAAATCAAAGAGTTGCAAGGTTATTTTTTTCTCATTGGGGTTTTTGTTTCATTACTCATTTTTACTATTTTATTTTTGTTATATAATATGTAAATTTAATAAGTCAAGTTTGAAATTTTTTTTGATATATGCATTTTTATTTTCTTTATTTATTTCTAATGTATTAAATTTTTTAAGTTATTTTTCTTTTTTTGTTTCAGGGGGGGAACTAACGATCTTCTTGGATAAAAGTAGTGATAGTATTAAGAGGATTATTATTGGAGTATCATTCCTTATTATATTGATTATGGTTAAGGTTGATAAGAAAAGTTATAGTTGGAGTCTTTATAAATTATCCTTGTTTTTCTGTATATTATCGATTGCGCTTTATCAAAACTGGCAGTTATCCTGGAGGGTATTTGTTCCCGCAGCTACTTTAGGGAGTGCTATAGTTTTAGCGAATATAAGAAAGGATAATATAATCCCTTTTTTGGGGGTGGTTTTATCAACTATCCCCACAATGAGAATAATTTATAATTTATTATATCTAGGACATCCATAA	MFKKKSIFVFLGLLSSILLALPLAMQGGFDDSLVYYSQADYIWSYGLYDGLRAIYIQTNKFEPAMGLLFFIEGFIVTEKFYFLLLNLTLVNFITVLIYIKINEQSNTSISFIYAILLLSTYYIFSNNIYVWRTIISLYFFILFVFSKSKSCKVIFFSLGFLFHYSFLLFYFCYIICKFNKSSLKFFLIYAFLFSLFISNVLNFLSYFSFFVSGGELTIFLDKSSDSIKRIIIGVSFLIILIMVKVDKKSYSWSLYKLSLFFCILSIALYQNWQLSWRVFVPAATLGSAIVLANIRKDNIIPFLGVVLSTIPTMRIIYNLLYLGHP	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	94.75	gnl|BL_ORD_ID|109|hsp_num:0	127			369	498	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0000788.1|O-antigen_18 # 11106 # 12377 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=15bp;gc_cont=0.302	BGC0000788.1|O-antigen_18 	11106	12377	+	Loose	1300	25.7942	mdtO	31.03	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTTAAGAACAAAAAAAAAGCAGAGATGATAAAAAATGGAATATCTAATTATGTTTGCGTAGCATGGATGGGTGGAATTAGTATTCTGATTTTACCCTATTATCTGCATATACTTGGTGCCACCCAGTGGGGAATAGTAGCTATTTGCATTACTATACAGGCGTTAATGTTATTAGCTGATATGGGCATGGCTCAAATAATGCCAAGAGATATAGCCAAGCATAGTTTTGATAAAAACAAATTATATGCTATATATAATGGCTTTTATAAGGTATATTTATATCTTGCTTTTTTTATATCAACGACAATTATTATATTAAGTTATTATATTGTCTATCATTGGCTAAATGTAACAATTAAATATGACACTTTGGTTTGTATTATATTGTTAGCTATTCAATTTTTATTCCAATTCCCTAATAATGCAAATATAGGTTTCTGGAATGGAACATTGCAACAACATAAGTCGAATATCAGACAATGTTTTTTCTTTACGTTAAGACATATTATCGCTTTTACTCTTGTTTATAACTGGCCATCGGCGATATCATATCAAATCGGTTTTTGTTTAGTTGCTATATGCGAATCTTTAATAAACTCTTATAATATTTATTCTGAATTGAAAAGCTACAATTGTAAAAAAGAACATTTGTTTAGTATAAAAAAAATATTTTCCGAAAGCGGTGCTTTATCTGCTGCTGTACTTATTGGATTACTGGTAACCCAACTAGACAGAATAATCCTTAGCCGAACGCTTGATTTAACCATCTACGGGTATTATATATTAGGAGCAACGCTGGCTCAATATTTTCTTCAGCTACAGTACCCACTACTTAGAGTTTTTTTTCCGCGTTTAGCTATTAACTTAAATAAAAAGACAATTTTTGCATTGTTAAAATGCATGTGTCTTTTCTGCGTACTTCCATGTATTATTATGATAATAATAGCCCCATACTTTTTGAAGTATTGGTTGAATAATTATCAAGCAGCAATGGTAGCTTTATGGCCTCTTAGGTTAATTCTTGGTGCAATAGCAATTAATTCTCTTTATAATATTATTTATCAAGTTCTTTTAATCAAAGAAGAAACTAAATTGATACTTTCTATAAATATAATTTCGCTTGTGGCTGTATCGGTTGTTGTTTCCGCTTTGGCTGAAAGATTGAGTGTAATAGCTGGTGGTATTGGGTGGGTAGTTTGTGCTTTCATACAATTGATAATTTCAATAATTTGGTTTTTTAAAAAAAGGGATAGTATATTATCATGTTAA	MFKNKKKAEMIKNGISNYVCVAWMGGISILILPYYLHILGATQWGIVAICITIQALMLLADMGMAQIMPRDIAKHSFDKNKLYAIYNGFYKVYLYLAFFISTTIIILSYYIVYHWLNVTIKYDTLVCIILLAIQFLFQFPNNANIGFWNGTLQQHKSNIRQCFFFTLRHIIAFTLVYNWPSAISYQIGFCLVAICESLINSYNIYSELKSYNCKKEHLFSIKKIFSESGALSAAVLIGLLVTQLDRIILSRTLDLTIYGYYILGATLAQYFLQLQYPLLRVFFPRLAINLNKKTIFALLKCMCLFCVLPCIIMIIIAPYFLKYWLNNYQAAMVALWPLRLILGAIAINSLYNIIYQVLLIKEETKLILSINIISLVAVSVVVSALAERLSVIAGGIGWVVCAFIQLIISIIWFFKKRDSILSC	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	61.93	gnl|BL_ORD_ID|1893|hsp_num:0	2056			204	291	acriflavine; puromycin
BGC0000788.1|O-antigen_19 # 12371 # 13165 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.292	BGC0000788.1|O-antigen_19 	12371	13165	+	Loose	550	28.4906	PmrF	23.67	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGTTAACAGAAGTCAGACCTGTTTCTACTACTAAACCGCTAGTATCAGTTATTTTACCTGTAAATAAATTTAATCCTTATTTAGATAGGGCAATTCATAGTATTTTATCACAATCTTATCCTTCAATTGAATTGATTATAATAGCAAATAATTGCACAAATGATTTTTTTGATGCTTTAAAGAAAAGAGAATGTGAAACTATAAAGGTGCTTAGAACAAATATCGCATATTTACCATATTGTTTAAATAAGGGGCTTGATCTTTGTAATGGAGATTTTGTTGCCCGCATGGATTCTGATGATATATCACATCCTGAAAGGATTGATCGACAAGTTGACTTTTTAATAAATAATCCGGATATAGATGTCGTTGGCACCAATGCAGTATATATTGATGAGGACGATATTGAACTTGAGAAAAGTAATTTGCCTGTAAATAACAATGCCATAAGAAAAATGCTACCCTACAAATGCTGTTTAGTACATCCTTCAGTAATGTTTAGAAAAAATGTGGTAATAACCTCTGGTGGGTATATGTTTGCAAATTATTCTGAAGATTATGAGTTATGGAATAGATTGGCAGTGGAGGGAAGGAATTTTTATAATTTATCTGAATATTTGCTTTATTATCGACTTCATAATAATCAAAGTACATCAAAGAATAACTTATTTATGGTTATGGCCAATGATGTGGCAATTAAAGTTAAATATTTTTTGTTAACTAAAAAAATAAGTTATCTTTTGGGGATTATTAGGACTGTTTTTTCTGTTTTTTATTGTAAATATATAAAGTGA	MLTEVRPVSTTKPLVSVILPVNKFNPYLDRAIHSILSQSYPSIELIIIANNCTNDFFDALKKRECETIKVLRTNIAYLPYCLNKGLDLCNGDFVARMDSDDISHPERIDRQVDFLINNPDIDVVGTNAVYIDEDDIELEKSNLPVNNNAIRKMLPYKCCLVHPSVMFRKNVVITSGGYMFANYSEDYELWNRLAVEGRNFYNLSEYLLYYRLHNNQSTSKNNLFMVMANDVAIKVKYFLLTKKISYLLGIIRTVFSVFYCKYIK	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	81.99	gnl|BL_ORD_ID|1937|hsp_num:0	2014			6	489	polymyxin B
BGC0000788.1|O-antigen_20 # 13176 # 13931 # 1 # ID=1_20;partial=00;start_type=TTG;rbs_motif=AAA;rbs_spacer=14bp;gc_cont=0.327	BGC0000788.1|O-antigen_20 	13176	13931	+	Loose	550	40.0466	PmrF	31.63	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	TTGAAAACAGTTAGCGTTGTTATTCCGTGTTTTAACAGTATTGGTACTATTGATCAAGCGCTAAATTCAGTTTATAAGCAAACCTATAATCTTTTGGAAATTATATGTATAGATGATTGTTCAATTGATAATACATATGAACATATAAAAAACAATCATCCTACAGTGAAGCTTTTTAAGAATAAAAATAATATGGGGCCAGCTGCCAGCAGAAATATCGGTGCCTCATATTGCTCTGGAGAATTTATAGCTTTTTTAGATGCTGATGATACTTGGTTTTCAGATAAAACAAAACTGCAAATGGCTTTAATTGAAAGGTATGGGCTTGATTTTATTGGATCATCATTTGTAGTAGCTAAAAGTGAAACCGAAACGAATACATCAACATGTCGCATAATCACTACTAGAGAGTTAGCATTCAAAAATTATTTCCCAACACCGTCAGTTATCCTTCGAAAGGATTTAGTTCGTTTTGATGAATCGATGGGGTTCGCTGAAGACTATGATTTATGGTTGAGGCTATCAATAGCAAACTGTGTTATGGGATTTATAGATCAGCCACTGGTTGCTCTTGGGAAACCTAGTTTTGGTTACTCAGGATTAAGTTCAAATCTATTTAGAATGCAATGCGGTGAATTAAAATCTTTATCAAACTCTCTAAAAAAGGATTTGGTTTATTATTTTGCTATAATGTGGTCAATTCTAAAATTTTTACGTAGATTAGTTATTGTTTCATTTAGGCGCATCCTAAGTTAA	MKTVSVVIPCFNSIGTIDQALNSVYKQTYNLLEIICIDDCSIDNTYEHIKNNHPTVKLFKNKNNMGPAASRNIGASYCSGEFIAFLDADDTWFSDKTKLQMALIERYGLDFIGSSFVVAKSETETNTSTCRIITTRELAFKNYFPTPSVILRKDLVRFDESMGFAEDYDLWLRLSIANCVMGFIDQPLVALGKPSFGYSGLSSNLFRMQCGELKSLSNSLKKDLVYYFAIMWSILKFLRRLVIVSFRRILS	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	77.95	gnl|BL_ORD_ID|1937|hsp_num:0	2014			18	306	polymyxin B
BGC0000788.1|O-antigen_21 # 14004 # 15410 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.522	BGC0000788.1|O-antigen_21 	14004	15410	+	Loose	1950	26.9498	MexB	26.03	3000378	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCAAGCAACAGATCGGCGTCGTCGGTATGGCAGTGATGGGGCGCAACCTCGCGCTCAACATCGAAAACCGTGGTTATACCGTCTCCGTTTTCAACCGCTCCCGTGAAAAGACCGAAGAAGTGATTGCCGAGAATCCCGGCAAAAAGCTGGTGCCTTATTACACGGTGAAAGAGTTTGTTGAATCCCTTGAAACGCCTCGTCGTATCCTGTTAATGGTGAAAGCGGGCGCAGGTACTGACGCAGCCATTGATTCGCTTAAACCGTATCTGGAAAAAGGCGATATCATTATTGACGGCGGCAACACCTTCTTCCAGGACACGATCCGTCGCAATCGCGAGCTGTCTGCGGAAGGTTTTAACTTTATCGGTACCGGTGTTTCCGGTGGCGAAGAGGGCGCGTTGAAAGGCCCATCCATTATGCCTGGCGGTCAGAAAGATGCCTATGAACTGGTGGCGCCGATCCTGACGAAGATTGCTGCCGTGGCGGAAGATGGCGAACCGTGCGTGACCTATATTGGTGCGGATGGTGCTGGTCACTACGTCAAGATGGTCCACAATGGTATTGAATATGGCGATATGCAGCTTATTGCCGAAGCGTATTCGTTGCTGAAAGGAGGCCTGAACCTCAGCAATGAAGAGCTGGCGAGCACCTTTACTGAGTGGAATAACGGCGAGCTGAGCAGTTATCTGATCGACATCACTAAAGACATCTTCACTAAAAAAGATGAAGACGGAAACTACCTGGTGGATGTCATTCTTGATGAAGCCGCCAACAAAGGGACCGGTAAATGGACCAGCCAGAGCGCGCTGGATCTGGGCGAACCGCTGTCGCTGATTACCGAATCCGTCTTTGCGCGTTACATCTCTTCGTTGAAAGCGCAACGTGTTGCCGCATCTAAAGTGCTCTCCGGGCCGAAAGCGCAGCCGGCGGGTGACAAAGCGGAATTTATCGAGAAAGTGCGTCGCGCGCTGTATCTTGGCAAGATCGTCTCCTATGCGCAGGGCTTCTCGCAGCTACGCGCCGCGTCTGATGAATATCACTGGGATCTCAACTACGGTGAGATTGCTAAGATTTTCCGTGCGGGCTGTATCATTCGCGCTCAGTTCCTGCAGAAGATCACCGATGCTTATGCTGAAAACGCTGATATTGCCAATTTGCTGTTAGCGCCTTACTTCAAGAAAATTGCTGATGAGTACCAGCAGGCGCTGCGCGATGTCGTGGCTTACGCGGTGCAGAACGGCATTCCGGTGCCGACATTCTCTGCAGCGGTGGCCTATTATGACAGCTATCGCGCCGCAGTACTGCCAGCTAACCTGATTCAGGCGCAGCGTGACTACTTTGGTGCGCACACCTATAAACGTACAGATAAAGAAGGCATTTTCCATACCGAATGGTTGGAATAA	MSKQQIGVVGMAVMGRNLALNIENRGYTVSVFNRSREKTEEVIAENPGKKLVPYYTVKEFVESLETPRRILLMVKAGAGTDAAIDSLKPYLEKGDIIIDGGNTFFQDTIRRNRELSAEGFNFIGTGVSGGEEGALKGPSIMPGGQKDAYELVAPILTKIAAVAEDGEPCVTYIGADGAGHYVKMVHNGIEYGDMQLIAEAYSLLKGGLNLSNEELASTFTEWNNGELSSYLIDITKDIFTKKDEDGNYLVDVILDEAANKGTGKWTSQSALDLGEPLSLITESVFARYISSLKAQRVAASKVLSGPKAQPAGDKAEFIEKVRRALYLGKIVSYAQGFSQLRAASDEYHWDLNYGEIAKIFRAGCIIRAQFLQKITDAYAENADIANLLLAPYFKKIADEYQQALRDVVAYAVQNGIPVPTFSAAVAYYDSYRAAVLPANLIQAQRDYFGAHTYKRTDKEGIFHTEWLE	MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ	44.74	gnl|BL_ORD_ID|1789|hsp_num:0	1925			1758	1941	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000788.1|O-antigen_22 # 15484 # 15573 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.389	BGC0000788.1|O-antigen_22 	15484	15573	-	Loose	450	20.0162	mreA	26.09	3007050	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTACGTCCGACCATTCCGGTTGAACCCGTCAACAGAATTTTCATATCACCTCTAGCGTATTACCTAATAGATATATCTAACTTTTAG	MLRPTIPVEPVNRIFISPLAYYLIDISNF	MMKIHYINDYKDIQAKEDCVLVLGYFDGLHLGHKALFDKAKKIATEKNLKIVVLTFNETPRLTFARFQPELLLHLTSPEKRSEKFQEYGVDELYLMNFTSHFSKVSSDLFIKKYIYGLRAKAAVVGFDYKFGHNRTSGDYLARNFKGPVYIIDEISEGGEKISSTRIRQLITEGNVEKANQLLGYEFSTCGMVVHGDARGRTIGFPTANLAPINRTYLPADGVYISNVLINGKYYRAMTSIGKNITFGGTELRLEANIFDFDGDIYGETIEIFWLKRIREMVKFNGIDDLVKQLKKDKEIALNWKKDSQTL	9.32	gnl|BL_ORD_ID|4755|hsp_num:0	5749			615	684	
BGC0000788.1|O-antigen_23 # 15635 # 16450 # 1 # ID=1_23;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.308	BGC0000788.1|O-antigen_23 	15635	16450	+	Loose	500	26.5646	APH(3')-VIIa	27.08	3002654	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	TTGCTTGATAATAAAGCTGTCTATAACTATATCTCATGCTATTCTCCTGATTTAATTATTCATGCTGCAGGTTTAGTTGGTGGAATACAAGCAAATATAAAACACCCAGTTGATTTTCTAGTGTCAAACCTAATGATGGGGATTAACATTGTAAATGAGGCTAAAAATTGTGGTGTAAAGCATTTTATAAATTTAGGAAGTTCTTGTATGTATCCTAAAGATATTGATACAGCAATTTCTGAAGATGCTTTGCTTACAGGTAAGTTAGAGGATACTAATGAAGGATATGCAATTGCCAAAATCACTGTAGCAAAACTGTGTGAATATATAACTAGAGAAAATAAAGAGTATCATTATAAAACCATCATACCATGTAATCTATATGGAAAATATGATAAATTTGATGAAAATTCCTCACATATGATTCCTGCTGTTATAAATAGAATACATAATGCAAAGATTAATAATATTAAAGTAATTGATATTTGGGGGGATGGTGAGTCCCGCCGTGAATTTATGTATGCAGAAGATTTGGCTAATTTTATTTACCAGGTAATTCCAAACATCCAACGACTGCCAAATATGCTGAATGTTGGATTAGGTCATGATTTTACGATTAATGATTATTACAGAATCATAGCTGAAGAAATAGGGTATACAGGTGGTTTTACTCATGATTTAACAAAGCCTGTCGGTATGAGAAGGAAGCTAGTTGATATCAGTTTGTTGAAAGAATTTGACTGGAAATATCAGTTTGAATTGAAAGATGGTATAAAAGAAACTTATAAATACTATTTGGAGAATATATATAAATGA	MLDNKAVYNYISCYSPDLIIHAAGLVGGIQANIKHPVDFLVSNLMMGINIVNEAKNCGVKHFINLGSSCMYPKDIDTAISEDALLTGKLEDTNEGYAIAKITVAKLCEYITRENKEYHYKTIIPCNLYGKYDKFDENSSHMIPAVINRIHNAKINNIKVIDIWGDGESRREFMYAEDLANFIYQVIPNIQRLPNMLNVGLGHDFTINDYYRIIAEEIGYTGGFTHDLTKPVGMRRKLVDISLLKEFDWKYQFELKDGIKETYKYYLENIYK	MKYIDEIQILGKCSEGMSPAEVYKCQLKNTVCYLKKIDDIFSKTTYSVKREAEMMMWLSDKLKVPDVIEYGVREHSEYLIMSELRGKHIDCFIDHPIKYIECLVNALHQLQAIDIRNCPFSSKIDVRLKELKYLLDNRIADIDVSNWEDTTEFDDPMTLYQWLCENQPQEELCLSHGDMSANFFVSHDGIYFYDLARCGVADKWLDIAFCVREIREYYPDSDYEKFFFNMLGLEPDYKKINYYILLDEMF	108.40	gnl|BL_ORD_ID|226|hsp_num:0	251			75	348	neomycin; kanamycin A
BGC0000788.1|O-antigen_24 # 16447 # 17613 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.344	BGC0000788.1|O-antigen_24 	16447	17613	+	Loose	500	28.4906	CARB-7	24.44	3002246	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	ATGATTAACTATCCATTAGCAAGTAGCACTTGGGATGATTTGGAATATAAAGCAATTCAATCGGTTATAGACTCTAAAATGTTTACGATGGGGGAATGTGTAAAAAAATACGAAACTCAATTCGCAGAGACATTTGGAAGCAAATATGCCGTGATGGTTAGCTCAGGTTCTACAGCTAATTTATTAATGATTGCTGCCTTGTTCTTGACGAAAACTCCGAAATTAAAAAAAGGTGATGAAATAATAGTTCCGGCCGTTTCTTGGGCAACTACTTATTATCCGTTGCAGCAATATGGTCTGAAAGTAAAATTTGTTGATATCGATATAAATACTTTGAATATTGACATCGAGAGTTTAAATGAAGCTGTTACAGATAATACCAAAGCAATACTTACGGTAAACTTATTAGGTAATCCTAATAATTTCGATGAGATTAGGAAGATAATTGGTGGCAGAGATATTATCTTATTGGAAGACAACTGTGAGTCTATGGGGGCAATGTTTAATAGTAAATGTGCAGGTACCTTCGGTTTGATGGGGACATTTAGTTCATTTTATTCTCATCACATTGCTACGATGGAAGGTGGGTGTATTGTTACTGATGACGAAGAAATTTATCATATATTATTATGCATTAGAGCTCACGGCTGGACGCGAAACTTACCAAAAAATAATAGAGTTACTGGTATGAAGAGTGATGATCAATTTGAAGAGTCATTCAAATTTGTTTTGCCAGGTTATAATGTTAGACCACTAGAAATGAGCGGTGCAATAGGCATAGAACAATTAAAAAAATTGCCAGGATTTATTTCAGTGAGAAGGAAAAATGCTGAGTATTTTCTCGAAAAATTTAAAGACCATCCATACTTGGACGTGCAACAAGAAACTGGCGAGAGTAGTTGGTTCGGTTTCTCATTTATCATAAGGAAAGGTTCTGGTGTTATCAGGAAAGAGCTTGTTGAAAAATTGAATTCGGCAAGGATTGAGTGTAGACCTATCGTTACTGGTAATTTCCTGAAAAATAAAGATGTTCTTAAGTACTTCGACTATACCGTTCATAACAATGTAGTTAACGCTGAGTATTTAGACAAGAATGGTCTTTTCGTTGGTAACCATCAGATAGAATTATTTAATGAAATTGATTATCTCAGAAAAATATTGAAATAA	MINYPLASSTWDDLEYKAIQSVIDSKMFTMGECVKKYETQFAETFGSKYAVMVSSGSTANLLMIAALFLTKTPKLKKGDEIIVPAVSWATTYYPLQQYGLKVKFVDIDINTLNIDIESLNEAVTDNTKAILTVNLLGNPNNFDEIRKIIGGRDIILLEDNCESMGAMFNSKCAGTFGLMGTFSSFYSHHIATMEGGCIVTDDEEIYHILLCIRAHGWTRNLPKNNRVTGMKSDDQFEESFKFVLPGYNVRPLEMSGAIGIEQLKKLPGFISVRRKNAEYFLEKFKDHPYLDVQQETGESSWFGFSFIIRKGSGVIRKELVEKLNSARIECRPIVTGNFLKNKDVLKYFDYTVHNNVVNAEYLDKNGLFVGNHQIELFNEIDYLRKILK	MKSLLVFALLMPSVVFASSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQRFPLTSTFKTIACAKLLYDAEHGKVNLNSTVEIKKADLVTYSPVLEKQVGKPITLSDACLATMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNAITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADRSGAGGFGARSITAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR	134.72	gnl|BL_ORD_ID|1322|hsp_num:0	1443			255	471	
BGC0000788.1|O-antigen_25 # 17768 # 17899 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.333	BGC0000788.1|O-antigen_25 	17768	17899	+	Loose	550	21.9422	IMI-5	38.46	3001862	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IMI beta-lactamase	ATGAATTTTTATATTTATATATATCACCTATACAAAATTGCTGATACTTACGCCAATAAAAGTCAGTGCCAGTTTTCTCTAGCCGTTGCGTATAATATATCTGCCTTACAGGTAGCTTGTCCGATTACTTGA	MNFYIYIYHLYKIADTYANKSQCQFSLAVAYNISALQVACPIT	MSTTLRKSKPAFLLGSFLMSISLYSYANENGIDEIKNLEKKFNGRIGVYALDTGSGKSFAYRANERFPLCSSFKGFLAASVLKGSQDKQLNFSEIVNYNTRSLEPNSPITAKYKEQGMPLGEMAAAALQYSDNAATNIILERYIGGPVGMTKFMRSIGDEEFRLDRYELDLNTAIPGDERDTSTPEAVGKSLKNLALGNILNDSEKETYQTWLKGNTTGAARIRSSVPREWVVGDKTGTCGAYGTANDYAVVWPDDRAPLIISVYTTKYEKDAKHEEEFIAEASRIAIKTLN	14.73	gnl|BL_ORD_ID|3607|hsp_num:0	4676			252	330	
BGC0000788.1|O-antigen_26 # 17916 # 18053 # -1 # ID=1_26;partial=00;start_type=TTG;rbs_motif=AAA;rbs_spacer=15bp;gc_cont=0.486	BGC0000788.1|O-antigen_26 	17916	18053	-	Loose	600	21.9422	oleC	72.73	3003748	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGGGGGCCAACTTTTGGGGTGCAGTCAAGGAGCGCTCCGGGTCTAGATTTACTGCTGGGCTAAATCAGTTTAATGCGGCAATGCCGTATCAACCCCGACATCTTCGCAGACATATTGGAATACATAAATGCGAATAA	MGANFWGAVKERSGSRFTAGLNQFNAAMPYQPRHLRRHIGIHKCE	MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGDGVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPLAGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDEVFLSLTGHRASAPQDAEPARQEVAV	13.85	gnl|BL_ORD_ID|2050|hsp_num:0	2264			198	231	oleandomycin
BGC0000788.1|O-antigen_27 # 18075 # 18410 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=13bp;gc_cont=0.482	BGC0000788.1|O-antigen_27 	18075	18410	+	Loose	500	25.0238	GIL-1	25.45	3006888	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	GIL beta-lactamase	ATGGCAAAGCCCAGGTATTCACTCAAAACCAGACTGGCAGTAATCAGACACTACCTCTTCGGTAATAATGGGACACACCGAACCGCAGAACGATCTGGTGTCGAAAGAGCATCTGTTTGTCGCCGGGTCAGAGCATGGCAACTACACGATATTGATGGCATAAGCTGGAAAAATGACCGCCACTCCCCGGAGTTCATAGCTGCTGTTGTTCGGACGGTGCTCAATGGAGAACTTTCGAAGCGAGAAGCCGCTGCACGGTTTAATATCTCAAATGAAATCATTGTCCGACACTGGGTAAATGTCTACAAAGATGCTGGATCAAATCAAAGGGCCTGA	MAKPRYSLKTRLAVIRHYLFGNNGTHRTAERSGVERASVCRRVRAWQLHDIDGISWKNDRHSPEFIAAVVRTVLNGELSKREAAARFNISNEIIVRHWVNVYKDAGSNQRA	MPHFRLALIPLLTAFCLPAFAHPTTLNKVKEAESQLTARVGYAELDLTSGEILESYRLQERFPMMSTFKVLLCGAVLARVDAGKERLDRRIPFSRRDLVEYSPVTEKHLTDGMTVGELCDAAITMSDNTAANLLLTAIGGPQGLTAFLRTTGDRVTRLDRWEPELNEALPGDKRDTTTPENMAQTLRQLLTGKILTTTSQQQLTHWMVTDKVAGPLLRSVLPAGWFIADKTGAGARGSRGIVAALGPDGKPSRIVVIYITESQATMAERNRQIAGIGATLIQHWDE	38.81	gnl|BL_ORD_ID|3561|hsp_num:0	4630			516	657	
BGC0000788.1|O-antigen_28 # 18453 # 18659 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.338	BGC0000788.1|O-antigen_28 	18453	18659	+	Loose	1900	26.5646	MuxC	60.0	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACTGTCCAGGTTTATGGGACAGTTCAAATACCGGGCTTTTTTTTATCTCTATTCTTATTGATTTATCGCGTTTGCTTAATATTAACTTAATAATCTGTGTTTATCGTAATAAAGATAATCTGAATTGTTTTCGTCTGCGTTGCACTTCATTTACTCAGGCGTTAAAACTTTACTCTCTTGTCAGGATGCGAAACACATCATGA	MNCPGLWDSSNTGLFFISILIDLSRLLNINLIICVYRNKDNLNCFRLRCTSFTQALKLYSLVRMRNTS	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	6.56	gnl|BL_ORD_ID|2367|hsp_num:0	2720			1812	1857	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000788.1|O-antigen_29 # 18691 # 19857 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=15bp;gc_cont=0.438	BGC0000788.1|O-antigen_29	18691	19857	+	Strict	700	716.072	ugd	89.18	3003577	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAAATCACGATATCCGGGACGGGTTATGTTGGCTTGTCTAATGGTTTGCTTATTGCACAACACCATGATGTGGTGGCGTTAGACATTGTCCCTTCCCGTGTTGAACTGTTAAATGATCGGATATCTCCGATTGTTGATAAAGAAATTCAGCAATTTTTAAAGGAAGATAACATCAGGTTCAGGGCAACGCTGGATAAGTTTGATGCGTACCAGAATGCAGATTACGTCATCATTGCTACGCCTACGGATTACGATCCAAAAACCAACTATTTTAATACGTCCAGTGTGGAGTCGGTCATTCAGGATGTGACAAGCATTAACCCTGCAGCCGTTATGATCATTAAGTCTACGGTGCCGGTTGGTTTCACTGCGGCAATGCGTCAGAAGTTTGCGACAGAAAATATCATTTTCTCCCCGGAATTTTTACGTGAAGGTAAAGCCCTTTATGATAACCTTTATCCCTCGCGTATCGTGATCGGCGAACAGTCTGAACGCGCCAGAGAATTTGCCGCGTTACTCCAGGAAGGGGCCATTAAGCAGGATATTCCAACACTGTTTACAGATTCCACTGAAGCAGAAGCCATTAAACTTTTCGCCAATACTTATCTCGCTATGCGAGTCGCTTATTTTAATGAATTAGACAGTTATGCTGAAACGTTAGGGTTAAATACCCGACAAATTATTGAAGGGGTGTGCCTCGACCCGCGTATTGGCAATCATTATAATAATCCCTCTTTTGGTTATGGCGGATATTGTTTGCCAAAAGATACCAAACAGTTGCTGGCTAATTATCAGTCGGTGCCTAATAATATTATCTCCGCTATCGTTGAAGCAAACCGTACACGTAAAGATTTTATTGCCGACGCAATCCTCGCCAGAAAGCCTAAGGTGGTGGGCATTTATCGCCTGATAATGAAGAGTGGCTCCGATAACTTTCGTGCTTCATCGATTCAGGGGATTATGAAGCGCATCAAAGCGAAAGGCGTAGAGGTCATCATCTATGAACCGGTAATGCAAGAAGATGCTTTCTTTAACTCTCGCCTTGAGCGTGATTTGCGCTGCTTTAAGCAGCAGGCGGATGTCATTATTTCCAACAGGATGGCGGCAGAGCTTTTGGATGTCGCTGAAAAAGTGTATACCCGCGATCTTTTCGGTAGTGATTAA	MKITISGTGYVGLSNGLLIAQHHDVVALDIVPSRVELLNDRISPIVDKEIQQFLKEDNIRFRATLDKFDAYQNADYVIIATPTDYDPKTNYFNTSSVESVIQDVTSINPAAVMIIKSTVPVGFTAAMRQKFATENIIFSPEFLREGKALYDNLYPSRIVIGEQSERAREFAALLQEGAIKQDIPTLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAETLGLNTRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNIISAIVEANRTRKDFIADAILARKPKVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMQEDAFFNSRLERDLRCFKQQADVIISNRMAAELLDVAEKVYTRDLFGSD	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	100.00	gnl|BL_ORD_ID|894|hsp_num:0	842			0	1164	polymyxin B
BGC0000788.1|O-antigen_30 # 19957 # 20124 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.411	BGC0000788.1|O-antigen_30 	19957	20124	-	Loose	500	22.7126	OXA-679	33.33	3005887	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCGATAATAACGGCTACAATAATGGTCATCTTCCCTCGCCATAACTGTAGCAATAAATCAATCAAATCAATCTGTTCCGGATCGTTCCCACGCCCGGAAGACGTTTTACTATCCACTGTCATAGATACCCTAACTAAAAAAAGGATGAAGCTGGAAACAGTGTAG	MAIITATIMVIFPRHNCSNKSIKSICSGSFPRPEDVLLSTVIDTLTKKRMKLETV	MRTRLFPLLSISISIFLSACSSPFIEPKDILPISTTDQTQQAIGSYFDEAQTQGVIVIKDGHNIDTYGNDLTRANTLYVPASTFKMLNALIGLENNKATVDEVFKWDGKKRSYSIWEKDMNLGEAMKLSAVPVYQELAKRIGVDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKITPIQEVEFADKLAHQELPFKQQVQKQVQDMLLIKEVEGNKIYAKSGWGMNVTPQVGWLTGWVEQPNGKKIAFSLNIEMKPNMPGSVRNEIALKSLKRLGII	19.93	gnl|BL_ORD_ID|3922|hsp_num:0	4992			12	111	cloxacillin; oxacillin; cefalotin
BGC0000788.1|O-antigen_31 # 20237 # 20872 # 1 # ID=1_31;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.520	BGC0000788.1|O-antigen_31 	20237	20872	+	Loose	2000	25.0238	Staphylococcus aureus mupA conferring resistance to mupirocin	22.83	3000521	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	TTGTACGGCGGGAATGCGCCCAAAATTTCTGAAGTCCAGTCCGGTTTTATTGGCCGCTTTAGCGCGGCGTTTTCCGCATTGGCGGAAGCGCTGGATAATCAGAAAGAACCGGAAAAGCTCACCATTGAGCAGTCAGTAAAGGGGCAGGCGCTGCCGCTCTCGGTTTCATATGTGAGTACTACTGCTGAAGGCGCGCAGCGCCGGCTGGCGGAATATATCCAACAGGTGGATGAAGAGGTCGCTAAGGAACTGGAAGTCGACCTGAAAGATAACATCACTCTGCAAACCAAAACGTTGCAGGAGTCCCTTGAGACGCAGGAAGTTGTGGCGCAGGAGCAAAAAGATCTGCGCATAAAACAAATCGAAGAAGCGTTGCGCTATGCGGATGAGGCCAAAATCACGCAGCCGCAGATTCAGCAAACCCAGGATGTTACCCAGGACACGATGTTCCTGCTGGGGAGCGATGCGCTAAAATCGATGATACAGAACGAAGCGACGCGTCCACTGGTCTTTTCTCCTGCCTATTACCAGACGAAGCAGACACTGTTGGATATTAAAAATCTGAAAGTGACTGCCGATACCGGTGCATGTCTATCGTTATGTGATGAAGCCGACGCTGCCGGTCCGTCGCGATAG	MYGGNAPKISEVQSGFIGRFSAAFSALAEALDNQKEPEKLTIEQSVKGQALPLSVSYVSTTAEGAQRRLAEYIQQVDEEVAKELEVDLKDNITLQTKTLQESLETQEVVAQEQKDLRIKQIEEALRYADEAKITQPQIQQTQDVTQDTMFLLGSDALKSMIQNEATRPLVFSPAYYQTKQTLLDIKNLKVTADTGACLSLCDEADAAGPSR	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	20.61	gnl|BL_ORD_ID|4699|hsp_num:0	2270			2322	2541	mupirocin
BGC0000788.1|O-antigen_32 # 21080 # 21481 # -1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.540	BGC0000788.1|O-antigen_32 	21080	21481	-	Loose	1200	24.6386	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones	26.09	3003459	protein variant model	N538K	n/a	fluoroquinolone antibiotic	antibiotic target alteration	fluoroquinolone resistant gyrB	GTGCTGAATGTCGTCAGCATTGCGCCGGATTGCGACAACGATACACTGCTGGTGCTGGCTAACCCTGTCGGGCCGACCTGCCACAAAGGTACCAGTAGCTGCTTTGGCGACGCCAGCCATCAATGGTTATTCCTGTATCAACTGGAGCAACTGCTGGCAGAGCGCAAAACCGCCGATCCGGCCAGCTCTTATACGGCGAAACTGTACGCCAGCGGTACCAAACGTATTGCACAAAAGGTTGGCGAAGAAGGTGTAGAAACCGCGCTGGCGGCCACCGTTAACGATCGTGTTGAGCTGACCAATGAAGCGTCTGATTTGATGTACCACCTGCTGGTACTGCTGCAGGATCAAGATCTCAACCTCACCGCCGTGATTGATAATCTCCGTAAGCGCCATCAATAA	MLNVVSIAPDCDNDTLLVLANPVGPTCHKGTSSCFGDASHQWLFLYQLEQLLAERKTADPASSYTAKLYASGTKRIAQKVGEEGVETALAATVNDRVELTNEASDLMYHLLVLLQDQDLNLTAVIDNLRKRHQ	MGKNEARRSALAPDHGTVVCDPLRRLNRMHATPEESIRIVAAQKKKAQDEYGAASITILEGLEAVRKRPGMYIGSTGERGLHHLIWEVVDNAVDEAMAGYATTVNVVLLEDGGVEVADDGRGIPVATHASGIPTVDVVMTQLHAGGKFDSDAYAISGGLHGVGVSVVNALSTRLEVEIKRDGYEWSQVYEKSEPLGLKQGAPTKKTGSTVRFWADPAVFETTEYDFETVARRLQEMAFLNKGLTINLTDERVTQDEVVDEVVSDVAEAPKSASERAAESTAPHKVKSRTFHYPGGLVDFVKHINRTKNAIHSSIVDFSGKGTGHEVEIAMQWNAGYSESVHTFANTINTHEGGTHEEGFRSALTSVVNKYAKDRKLLKDKDPNLTGDDIREGLAAVISVKVSEPQFEGQTKTKLGNTEVKSFVQKVCNEQLTHWFEANPTDAKVVVNKAVSSAQARIAARKARELVRRKSATDIGGLPGKLADCRSTDPRKSELYVVEGDSAGGSAKSGRDSMFQAILPLRGKIINVEKARIDRVLKNTEVQAIITALGTGIHDEFDIGKLRYHKIVLMADADVDGQHISTLLLTLLFRFMRPLIENGHVFLAQPPLYKLKWQRSDPEFAYSDRERDGLLEAGLKAGKKINKEDGIQRYKGLGEMDAKELWETTMDPSVRVLRQVTLDDAAAADELFSILMGEDVDARRSFITRNAKDVRFLDV	18.63	gnl|BL_ORD_ID|1994|hsp_num:0	2109			1599	1725	enoxacin; levofloxacin; moxifloxacin; gatifloxacin; lomefloxacin; nalidixic acid; norfloxacin; ofloxacin; trovafloxacin; grepafloxacin; sparfloxacin; pefloxacin
